[link|362|japan bioplastics association website] With more than 200 membership companies, JBPA promotes the recognition and the business development of Biodegradable Plastics” and “Biomass-based Plastics” in Japan. It is located in Tokyo. At present, JBPA’s president`is Mr Ryuichi TOMIZAWA (Mitsubishi Chemical Holdings).
[link|358|Hokudo Ltd website] is a public company with headquarters in Sapporo, Hokkaido. There are additional bioscience laboratories in Toyako-cho, Abuta-gun, Hokkaido, and in Ibaraki, Osaka Prefecture. The company breeds laboratory animals, sells laboratory-animal related products and services outside animal laboratories. Capital is 76 million Yen (~0,67 million €). The company was started in 1971, went […]
[link|351|Sumitomo Bakelite] is a chemical company with a focus on plastic materials. Headquarter are in Tokyo. Established in 1932, capital was ~ 37 billion Yen (~ 325 million €)(end of FY2009). Consolidated sales in FY2009 were 170.8 billion Yen (~ 1.5 billion €), and the company had 7.735 employees (consolidated). Director and President is Mr […]
[link|345|Two Cells website] An incorporated company two cel is a biotechnology venture business from Hiroshima University. Aiming at the spread of regeneration medicine, the mesenchymal stem cell (MSC) which is a kind of a somatic stem cell is targeted, and construction of the culture technology of the MSC circumference and a regeneration medicine system is […]
[link|328|DNA Chip Research website]is a startup company located in Yokohama, Kanagawa Prefecture, founded in 1999. It is focused on functional genomics-based technologies, e. g., DNA chips, and on various contract services. The company has 25 employees, 8 with Ph.D. Capital is 111 million Yen （6/2010）(~1 million €). Director is Mr Akira MATOJO, Honorary Director is […]
[link|324|MedGel website] is a privately-held RD company started in 2004 as a spin-off from Kyoto University. The company sells materials for animal tissue culture and is involved in tests on drug delivery systems. Capital is 100 million Yen (~ 900 T€). Chairman is Dr Tomohiko ASAHARA.
[link|313|Hiroshima Biomedical Co website] is a startup company located in Hiroshima. The company was founded in 2007 as a spin-off of Hiroshima University. It develops and sells chicken monoclonal antibodies, transgenic chicken and eggs. Capital is 10 million Yen (~ 89.000 €). It is located in the Hiroshima University Industry Cooperation Center and has 5 […]
[link|310|Japan Bioindustry Association website] is a non-profit organization dedicated to the promotion of bioscience, biotechnology and bioindustry located in Tokyo. It was established through the support and cooperation of industry, academia, and government (METI). President is Mr. Osamu NAGAYAMA (President of Chugai Pharmaceutical Co.), Chairman is Dr. Hiroshi HARADA (Professor emeritus, University of Tsukuba). Executive […]
[link|308|ReqMed website] was founded, in 1998, by Kyowa Hakko Kogyo Co. and Mr Tadashi MATSUMOTO to facilitate pharmaceutical companies in creating strategic alliances with innovative bio-pharmaceutical companies. In 1999, ReqMed became independent from Kyowa Hakko Kogyo Co. In 2000, Life Science Venture Fund (LSVF I), the first Japanese investment fund specializing in biotechnology, was created. […]